North America holds a significant share of the Radiotherapy Market, driven by the rising prevalence of cancer, increasing adoption of advanced radiation treatment technologies, and strong healthcare infrastructure. Growing investments in oncology care, favorable reimbursement policies, and the availability of sophisticated radiotherapy systems are supporting market expansion across the region.

According to The Insight Partners, The Radiotherapy Market is projected to reach US$ 10,170.80 million by 2028 from US$ 6,474.78 million in 2020; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028. The global radiotherapy market is witnessing a transformative phase as precision oncology, artificial intelligence, and advanced imaging technologies redefine cancer treatment worldwide. Radiotherapy remains one of the most widely used treatment methods for cancer, and its role continues to expand with innovations that make treatment faster, safer, and more personalized.

According to recent industry updates, the rising global cancer burden, aging population, and increasing investment…

North America is a prominent market for Capsule Filling Machines, driven by the expanding pharmaceutical, nutraceutical, and dietary supplement industries. Increasing demand for high-volume drug manufacturing, automation in production processes, and stringent quality standards are encouraging the adoption of advanced capsule filling equipment across the region.

According to The Insight Partners, Global Capsule Filling Machine Market is projected to reach US$ 290.92 million by 2028 from US$ 211.32 million in 2021; it is expected to grow at a CAGR of 4.7% during 2021 to 2028. The Capsule Filling Machine Market is witnessing strong momentum as pharmaceutical, nutraceutical, and contract manufacturing organizations continue shifting toward automation, traceability, and flexible production. With rising demand for capsules across medicines, supplements, and wellness products, manufacturers are investing in advanced capsule filling systems that improve accuracy, efficiency, and regulatory compliance.

Recent industry developments highlight how automation and smart manufacturing are reshaping the sector. For example, the integration…

North America holds a leading position in the Neurotoxin Market, driven by the growing demand for both aesthetic and therapeutic neurotoxin applications. The region benefits from advanced healthcare infrastructure, high consumer awareness of cosmetic procedures, and increasing use of neurotoxins for treating chronic migraine, muscle spasticity, cervical dystonia, and other neurological conditions.

According to The Insight Partners, the Neurotoxin Market size is expected to reach US$ 13,195.06 million by 2028 from US$ 6,622.36 million in 2022, registering a strong CAGR of 12.3% from 2023 to 2028. The impressive growth trajectory reflects the expanding patient base, increased healthcare spending, and ongoing product innovations that continue to strengthen demand globally. According to The Insight Partners, The global Neurotoxin Market is witnessing strong growth due to rising demand for minimally invasive cosmetic procedures and expanding therapeutic applications across neurology and pain management. Neurotoxins—primarily botulinum toxin products—are widely used in aesthetic medicine for wrinkle reduction and facial…

North America accounts for a significant share of the CIN & HR-HPV Treatment Market, driven by increasing awareness of cervical cancer prevention, widespread HPV screening programs, and strong adoption of advanced diagnostic and treatment options. The region's well-developed healthcare infrastructure and ongoing investments in women's health initiatives continue to support market growth.

 According to The Insight Partners, The CIN & HR-HPV treatment market size is expected to reach US$ 17,164.61 million by 2028 from US$ 11,635.17 million in 2022; the market is estimated to record a CAGR of 6.7% from 2023 to 2028. The CIN & HR-HPV Treatment Market is experiencing strong growth as healthcare systems intensify efforts to prevent cervical cancer through early diagnosis and treatment of high-risk human papillomavirus (HR-HPV) infections and cervical intraepithelial neoplasia (CIN). Rising screening programs, growing awareness of women’s health, and technological advancements in therapeutic solutions are shaping the market outlook through 2028.

Cervical cancer remains…

North America holds a substantial share of the Bioprocess Technology Market, driven by the strong presence of biopharmaceutical manufacturers, increasing biologics production, and continuous advancements in biotechnology. The region benefits from significant investments in research and development, adoption of single-use technologies, and growing demand for efficient bioprocessing solutions in drug development and manufacturing.

 According to The Insight Partners, Global Bioprocess Technology Market size was valued at US$ 30,897.49 million in 2022 and is projected to reach US$ 77,090.05 million by 2028; it is estimated to register a CAGR of 16.8% from 2023 to 2028.  The global bioprocess technology market is witnessing strong momentum as biopharmaceutical manufacturing rapidly transitions toward advanced, automated, and data-driven production models. Increasing demand for biologics, vaccines, and cell and gene therapies is pushing pharmaceutical companies to modernize manufacturing infrastructure and adopt cutting-edge

bioprocess solutions.

Get a Sample PDF - https://www.theinsightpartners.com/sample/TIPHE100001373

Bioprocess technologies play a critical role in upstream and…

North America represents a major share of the Glioma Treatment Market, supported by advanced oncology care infrastructure, increasing incidence of brain tumors, and strong investments in cancer research. The region benefits from widespread adoption of innovative treatment approaches, including targeted therapies, immunotherapies, and advanced surgical techniques, which are improving patient outcomes and driving market growth.

 According to The Insight Partners, Global Glioma Treatment Market revenue was valued at US$ 4,139.0 million in 2022 and the glioma treatment market size are projected to reach US$ 8,291.3 million by 2030. It is expected to register a CAGR of 9.1% during 2022–2030. The global Glioma Treatment Market is witnessing transformative growth as research breakthroughs, precision medicine, and advanced imaging technologies reshape the future of brain cancer care. Glioma, one of the most aggressive and complex brain tumors, continues to demand innovative therapeutic approaches, driving strong investment and collaboration across the pharmaceutical, biotechnology, and healthcare sectors. With rising awareness,…

North America holds a significant share of the Epilepsy Drugs Market, driven by the high prevalence of epilepsy, strong healthcare infrastructure, and widespread access to advanced antiepileptic medications. Increasing awareness of neurological disorders, favorable reimbursement policies, and ongoing research into novel treatment options continue to support market growth across the region.

 According to The Insight Partners, The epilepsy drugs market size is projected to grow from US$ 7.7 billion in 2022 to US$ 10.7 billion by 2030; it is estimated to record a CAGR of 4.1% during 2022–2030. Rising Research & Development (R&D) activities are likely to remain key trends in the market. The global Epilepsy Drugs Market is witnessing steady growth driven by the rising prevalence of neurological disorders, increased awareness, and continuous advancements in anti-epileptic therapies. As epilepsy remains one of the most common chronic neurological disorders globally, pharmaceutical companies are intensifying their focus on novel treatment approaches, improved…

The Microbiome Therapeutics Market is witnessing significant growth across North America, driven by increasing investments in microbiome research, rising prevalence of gastrointestinal disorders, and growing interest in precision medicine. North America remains the leading regional market due to its advanced healthcare infrastructure, strong presence of biotechnology companies, and supportive regulatory initiatives encouraging innovation in microbiome-based therapies.

According to The Insight Partners, The Microbiome Therapeutics Market size is expected to grow from US$ 375.92 million  in 2022 and to reach a value of US$ 813.38 million  by 2030; it is anticipated to record a CAGR of 10.1% from 2022 to 2030. The Microbiome Therapeutics Market is witnessing rapid transformation as scientific breakthroughs unlock the role of human microbiota in disease prevention and treatment.

Microbiome therapeutics focus on restoring microbial balance in the human body to treat conditions ranging from gastrointestinal disorders to metabolic diseases and cancer. With growing investment, expanding clinical pipelines, and increasing awareness…

The North American Rhodiola Root Powder Market is witnessing substantial growth due to increasing consumer awareness regarding natural health supplements and adaptogenic ingredients. Consumers across the region are actively seeking herbal products that support stress management, mental wellness, physical endurance, and immune health. Rhodiola root powder, derived from the Rhodiola rosea plant, has gained significant popularity owing to its potential benefits in reducing fatigue and improving cognitive performance.

According to The Insight Partners, the Rhodiola Root Powder Market size is expected to reach US$ 1,103.39 million by 2034 from US$ 698.15 million in 2025. The market is estimated to record a CAGR of 5.89% from 2026 to 2034. The growing demand for herbal dietary supplements, increasing adoption of adaptogens, and rising consumer preference for natural health solutions are among the key factors driving market growth globally.

Download Sample PDF – https://www.theinsightpartners.com/sample/TIPRE00025425

Market Overview

Rhodiola root powder is obtained from the roots of…